ℹ️
🇬🇧
Search
Search for people relevant for "Prognostic Value"
Prognostic Value
Person
Class
Person
Publication
Programmes
prof. MUDr. Ivan Špička CSc.
Academic staff at First Faculty of Medicine
278 publications
Publications
publication
10 years of experience with thalidomide in multiple myeloma patients: Report of the Czech Myeloma Group
2013 |
Central Library of Charles University
publication
Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trial
+1
2012 |
First Faculty of Medicine
publication
Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed multiple myeloma patients: subanalysis of the phase 3 VISTA study
2011 |
First Faculty of Medicine
publication
Gain of 1q21 Is an Unfavorable Genetic Prognostic Factor for Multiple Myeloma Patients Treated with High-Dose Chemotherapy
2010 |
First Faculty of Medicine
publication
Molecular cytogenetic study of immunofluorescently labeled plasma cells in patients with multiple myeloma enrolled in study CMG 2002
2008 |
First Faculty of Medicine
publication
Autologous transplantation in 495 multiple myeloma patients - Analysis from the Czech National Registry of Hematopoietic Stem Cell Transplantation
2007 |
First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Hradec Králové
publication
International Staging System required standardization of biochemical laboratory testing in multiple myeloma
2006 |
First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Gain/amplification of 1q21 is the most powerful genetic prognostic factor for patients treated by autologous stem cell transplantation
Publication without faculty affiliation
publication
Molecular cytogenetic study of immunofluorescently labeled plasma cells and prognostic significance of clonal chromosomal aberrations in 208 patients with multiple myeloma
Publication without faculty affiliation
publication
Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis
2023 |
First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Hradec Králové
Load more publications (268)
Loading network view...